GLP-1 Medications in India: Complete Guide (2026)
India is on the verge of a GLP-1 revolution. The semaglutide patent expired on March 20, 2026, unleashing over 50 generic brands from major Indian pharmaceutical companies including Dr. Reddy's (Obeda), Sun Pharma (Noveltreat, Sematrinity), Zydus (Semaglyn, Mashema, Alterme), and Lupin (Semanext, Livarise). This is expected to dramatically reduce costs and make GLP-1 medications accessible to millions of Indians.
Enzo's Tip
India is getting dozens of affordable semaglutide generics in 2026! Enzo tracks all brands equally — whether it's Obeda, Semaglyn, or the original Ozempic, your cat companion has you covered.
Quick Facts
| Country | India |
| Health System | Ayushman Bharat / Private |
| Currency | INR |
| GLP-1 Medications Available | 9+ |
Meet Enzo — your GLP-1 companion
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Available Medications in India
Local & Generic Brands
Join thousands tracking their GLP-1 journey with Enzo
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Frequently Asked Questions
Medical Disclaimer: Enzo is a tracking companion, not a doctor. Always consult your healthcare provider before starting, stopping, or changing any medication. The information on this page is for educational purposes only and should not be considered medical advice. Individual results may vary.